• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制白细胞介素 11 信号通路可减少非酒精性脂肪性肝炎小鼠模型中的肝细胞死亡及肝纤维化、炎症和脂肪变性。

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.

机构信息

Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.

Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.

出版信息

Gastroenterology. 2019 Sep;157(3):777-792.e14. doi: 10.1053/j.gastro.2019.05.002. Epub 2019 May 9.

DOI:10.1053/j.gastro.2019.05.002
PMID:31078624
Abstract

BACKGROUND & AIMS: We studied the role of interleukin 11 (IL11) signaling in the pathogenesis of nonalcoholic steatohepatitis (NASH) using hepatic stellate cells (HSCs), hepatocytes, and mouse models of NASH.

METHODS

We stimulated mouse and human fibroblasts, HSCs, or hepatocytes with IL11 and other cytokines and analyzed them by imaging, immunoblot, and functional assays and enzyme-linked immunosorbent assays. Mice were given injections of IL11. Mice with disruption of the interleukin 11 receptor subunit alpha1 gene (Il11ra1) mice and Il11ra1 mice were fed a high-fat methionine- and choline-deficient diet (HFMCD) or a Western diet with liquid fructose (WDF) to induce steatohepatitis; control mice were fed normal chow. db/db mice were fed with methionine- and choline-deficient diet for 12 weeks and C57BL/6 NTac were fed with HFMCD for 10 weeks or WDF for 16 weeks. Some mice were given intraperitoneal injections of anti-IL11 (X203), anti-IL11RA (X209), or a control antibody at different timepoints on the diets. Livers and blood were collected; blood samples were analyzed by biochemistry and liver tissues were analyzed by histology, RNA sequencing, immunoblots, immunohistochemistry, hydroxyproline, and mass cytometry time of flight assays.

RESULTS

HSCs incubated with cytokines produced IL11, resulting in activation (phosphorylation) of ERK and expression of markers of fibrosis. Livers of mice given injections of IL11 became damaged, with increased markers of fibrosis, hepatocyte cell death and inflammation. Following the HFMCD or WDF, livers from Il11ra1 mice had reduced steatosis, fibrosis, expression of markers of inflammation and steatohepatitis, compared to and Il11ra1 mice on the same diets. Depending on the time of administration of anti-IL11 or anti-IL11RA antibodies to wild-type mice on the HFMCD or WDF, or to db/db mice on the methionine and choline-deficient diet, the antibodies prevented, stopped, or reversed development of fibrosis and steatosis. Blood samples from Il11ra1 mice fed the WDF and given injections of anti-IL11 or anti-IL11RA, as well as from Il11ra1 mice fed WDF, had lower serum levels of lipids and glucose than mice not injected with antibody or with disruption of Il11ra1.

CONCLUSIONS

Neutralizing antibodies that block IL11 signaling reduce fibrosis, steatosis, hepatocyte death, inflammation and hyperglycemia in mice with diet-induced steatohepatitis. These antibodies also improve the cardiometabolic profile of mice and might be developed for the treatment of NASH.

摘要

背景与目的

我们通过肝星状细胞(HSCs)、肝细胞和非酒精性脂肪性肝炎(NASH)的小鼠模型研究了白细胞介素 11(IL11)信号在 NASH 发病机制中的作用。

方法

我们用 IL11 和其他细胞因子刺激小鼠和人成纤维细胞、HSCs 或肝细胞,通过成像、免疫印迹和功能测定以及酶联免疫吸附测定进行分析。给小鼠注射 IL11。用白细胞介素 11 受体亚单位 alpha1 基因(Il11ra1)敲除小鼠和 Il11ra1 小鼠给予高脂肪蛋氨酸和胆碱缺乏饮食(HFMCD)或含液体果糖的西方饮食(WDF),以诱导脂肪性肝炎;对照小鼠给予普通饲料。db/db 小鼠给予蛋氨酸和胆碱缺乏饮食 12 周,C57BL/6 NTac 给予 HFMCD 10 周或 WDF 16 周。一些小鼠在不同时间点给予腹腔注射抗 IL11(X203)、抗 IL11RA(X209)或对照抗体。收集肝脏和血液;血液样本通过生化分析,肝脏组织通过组织学、RNA 测序、免疫印迹、免疫组化、羟脯氨酸和质谱时间飞行分析进行分析。

结果

用细胞因子孵育的 HSCs 产生 IL11,导致 ERK 激活(磷酸化)和纤维化标志物的表达。给予 IL11 注射的小鼠肝脏受损,纤维化标志物、肝细胞死亡和炎症增加。在用 HFMCD 或 WDF 处理后,与同饮食的 Il11ra1 小鼠相比,Il11ra1 小鼠的肝脏脂肪变性、纤维化、炎症和脂肪性肝炎标志物表达减少。根据在 HFMCD 或 WDF 上给予野生型小鼠或 db/db 小鼠抗 IL11 或抗 IL11RA 抗体的时间,或在蛋氨酸和胆碱缺乏饮食上给予 Il11ra1 小鼠,抗体可预防、阻止或逆转纤维化和脂肪变性的发展。用 WDF 喂养的 Il11ra1 小鼠的血液样本和给予抗 IL11 或抗 IL11RA 注射的 Il11ra1 小鼠以及用 WDF 喂养的 Il11ra1 小鼠的血液样本,其血清脂质和葡萄糖水平低于未注射抗体或 Il11ra1 缺失的小鼠。

结论

中和阻断 IL11 信号的抗体可减少饮食诱导的脂肪性肝炎小鼠的纤维化、脂肪变性、肝细胞死亡、炎症和高血糖。这些抗体还改善了小鼠的心脏代谢特征,可能被开发用于治疗 NASH。

相似文献

1
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.抑制白细胞介素 11 信号通路可减少非酒精性脂肪性肝炎小鼠模型中的肝细胞死亡及肝纤维化、炎症和脂肪变性。
Gastroenterology. 2019 Sep;157(3):777-792.e14. doi: 10.1053/j.gastro.2019.05.002. Epub 2019 May 9.
2
Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH.肝细胞特异性 IL11 顺式信号传导驱动脂肪毒性,并构成从非酒精性脂肪性肝病到非酒精性脂肪性肝炎的转变基础。
Nat Commun. 2021 Jan 4;12(1):66. doi: 10.1038/s41467-020-20303-z.
3
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.脂质诱导的信号传导导致肝细胞释放炎性细胞外囊泡。
Gastroenterology. 2016 Apr;150(4):956-67. doi: 10.1053/j.gastro.2015.12.037. Epub 2016 Jan 5.
4
Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.肝细胞X盒结合蛋白1缺乏会加重高脂/高糖饮食喂养小鼠的肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2015 Dec 15;309(12):G965-74. doi: 10.1152/ajpgi.00132.2015. Epub 2015 Oct 15.
5
Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.脂肪组织来源的干细胞通过抑制白细胞介素-17 介导的炎症反应预防小鼠脂肪性肝炎的纤维化。
J Gastroenterol Hepatol. 2019 Aug;34(8):1432-1440. doi: 10.1111/jgh.14647. Epub 2019 Mar 31.
6
Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.富氢水通过增强 HO-1 及 Sirt 1 信号通路,通过 IL-10 发挥作用,从而防止非酒精性脂肪性肝炎导致的肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G450-G463. doi: 10.1152/ajpgi.00158.2020. Epub 2021 Jan 13.
7
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.GAS6/TAM 在非酒精性脂肪性肝炎进展中的功能作用提示 AXL 可作为治疗靶点。
Cell Mol Gastroenterol Hepatol. 2020;9(3):349-368. doi: 10.1016/j.jcmgh.2019.10.010. Epub 2019 Nov 2.
8
Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.成纤维细胞生长因子21通过促进蛋氨酸和胆碱缺乏饮食喂养的小鼠肝脏脂肪酸活化来限制脂毒性。
Gastroenterology. 2014 Nov;147(5):1073-83.e6. doi: 10.1053/j.gastro.2014.07.044. Epub 2014 Jul 30.
9
Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.吡格列酮可减轻磷脂酰乙醇胺N-甲基转移酶缺陷小鼠的肝脏炎症和纤维化。
Am J Physiol Gastrointest Liver Physiol. 2016 Apr 1;310(7):G526-38. doi: 10.1152/ajpgi.00243.2015. Epub 2016 Jan 21.
10
Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis.人羊膜上皮细胞及其可溶性因子可减轻非酒精性脂肪性肝炎小鼠的肝纤维化。
J Gastroenterol Hepatol. 2019 Aug;34(8):1441-1449. doi: 10.1111/jgh.14643. Epub 2019 Apr 2.

引用本文的文献

1
MCM7 promotes liver fibrosis by transcriptionally regulating IL11 via the SHCBP1-RACGAP1-STAT3 axis.MCM7通过SHCBP1-RACGAP1-STAT3轴转录调控IL11,从而促进肝纤维化。
Cell Death Dis. 2025 Aug 11;16(1):608. doi: 10.1038/s41419-025-07937-x.
2
Hepatocyte-derived Pumilio1-enriched exosomes inhibit HSC activation by suppressing tropomyosin-4 translation.肝细胞来源的富含Pumilio1的外泌体通过抑制原肌球蛋白-4的翻译来抑制肝星状细胞激活。
Hepatol Commun. 2025 Jul 21;9(8). doi: 10.1097/HC9.0000000000000759. eCollection 2025 Aug 1.
3
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
代谢功能障碍相关脂肪性肝病的抗纤维化治疗
JHEP Rep. 2025 Apr 11;7(8):101421. doi: 10.1016/j.jhepr.2025.101421. eCollection 2025 Aug.
4
Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis.衰老相关的白细胞介素-11驱动特发性肺纤维化的分子机制及靶向治疗
Eur J Med Res. 2025 Jul 2;30(1):542. doi: 10.1186/s40001-025-02755-5.
5
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC.代谢相关脂肪性肝病-代谢相关脂肪性肝炎-肝细胞癌(MASLD-MASH-HCC)发生发展中的微环境及MASH-HCC的相关治疗
Front Immunol. 2025 Apr 30;16:1569915. doi: 10.3389/fimmu.2025.1569915. eCollection 2025.
6
IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade.9MW3811对IL-11/IL-11R信号的抑制重塑了免疫肿瘤微环境并增强了PD-1阻断的抗肿瘤疗效。
NPJ Precis Oncol. 2025 May 12;9(1):138. doi: 10.1038/s41698-025-00913-w.
7
Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation.靶向肝星状细胞预防和治疗肝硬化及肝细胞癌:策略与临床转化
Pharmaceuticals (Basel). 2025 Mar 31;18(4):507. doi: 10.3390/ph18040507.
8
PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy.在格雷夫斯眼眶病中,丙酮酸脱氢酶激酶2增强的糖酵解通过白细胞介素11信号通路加重纤维化。
Front Immunol. 2025 Feb 13;16:1537365. doi: 10.3389/fimmu.2025.1537365. eCollection 2025.
9
Intra and inter-organ communication through extracellular vesicles in obesity: functional role of obesesomes and steatosomes.肥胖中通过细胞外囊泡进行的器官内和器官间通讯:肥胖小体和脂肪小体的功能作用
J Transl Med. 2025 Feb 20;23(1):207. doi: 10.1186/s12967-024-06024-7.
10
A multi-omic landscape of steatosis-to-NASH progression.从肝脂肪变性到非酒精性脂肪性肝炎进展的多组学全景图。
Life Metab. 2022 Dec 1;1(3):242-257. doi: 10.1093/lifemeta/loac034. eCollection 2022 Dec.